Similar and Different? Subjective Effects of Methylphenidate and Cocaine in Opioid-Maintained Patients

References

• Bruggisser, M., M. Bodmer, and M. E. Liechti. 2011. Severe toxicity due to injected but not oral or nasal abuse of methylphenidate tablets. Swiss Medical Weekly 141:w13267.
   PubMed Web of Science ®Google Scholar
• Bruggisser, M., M. Bodmer, and M. E. Liechti. 2012. [Methylphenidate misuse]. Praxis (Bern 1994) 101 (5):299–305. doi:10.1024/1661-8157/a000856.
   PubMedGoogle Scholar
• Candy, M., L. Jones, R. Williams, A. Tookman, and M. King. 2008. Psychostimulants for depression. Cochrane Database of Systematic Reviews (2):Cd006722. doi:10.1002/14651858.CD006722.pub2.
   PubMed Web of Science ®Google Scholar
• Carpenter, K. M., A. C. Brooks, S. K. Vosburg, and E. V. Nunes. 2004. The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: A controlled clinical trial. Drug and Alcohol Dependence 74 (2):123–34. doi:10.1016/j.drugalcdep.2003.11.015.
   PubMed Web of Science ®Google Scholar
• Castells, X., M. Casas, C. Perez-Mana, C. Roncero, X. Vidal, and D. Capella. 2010. Efficacy of psychostimulant drugs for cocaine dependence. Cochrane Database of Systematic Reviews (2):Cd007380. doi:10.1002/14651858.CD007380.pub3.
   PubMed Web of Science ®Google Scholar
• Collins, S. L., F. R. Levin, R. W. Foltin, H. D. Kleber, and S. M. Evans. 2006. Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD. Drug and Alcohol Dependence 82 (2):158–67. doi:10.1016/j.drugalcdep.2005.09.003.
   PubMed Web of Science ®Google Scholar
• Czoty, P. W., S. E. Martelle, R. W. Gould, and M. A. Nader. 2013. Effects of chronic methylphenidate on cocaine self-administration under a progressive-ratio schedule of reinforcement in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics 345 (3):374–82. doi:10.1124/jpet.113.204321.
   PubMed Web of Science ®Google Scholar
• Dursteler, K. M., E. Berger, J. Strasser, C. Caflisch, J. Mutschler, M. Herdener, and M. Vogel. 2015. Clinical potential of methylphenidate in the treatment of cocaine addiction: A review of the current evidence. Substance Abuse and Rehabilitation 6:61–74.
   PubMed Web of Science ®Google Scholar
• Dursteler-MacFarland, K. M., N. S. Farronato, J. Strasser, J. Boss, M. F. Kuntze, S. A. Petitjean, C. Burki, and G. A. Wiesbeck. 2013. A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription. Journal of Clinical Psychopharmacology 33 (1):104–08. doi:10.1097/JCP.0b013e31827bfff4.
   PubMed Web of Science ®Google Scholar
• Ebert, D., J. Krause, and C. Roth-Sackenheim. 2003. [ADHD in adulthood–guidelines based on expert consensus with DGPPN support]. Nervenarzt 74 (10):939–46.
   PubMedGoogle Scholar
• Garbe, E., R. T. Mikolajczyk, T. Banaschewski, U. Petermann, F. Petermann, A. A. Kraut, and I. Langner. 2012. Drug treatment patterns of attention-deficit/hyperactivity disorder in children and adolescents in Germany: Results from a large population-based cohort study. Journal of Child and Adolescent Psychopharmacology 22 (6):452–58. doi:10.1089/cap.2012.0022.
   PubMed Web of Science ®Google Scholar
• Grabowski, J., J. D. Roache, J. M. Schmitz, H. Rhoades, D. Creson, and A. Korszun. 1997. Replacement medication for cocaine dependence: Methylphenidate. Journal of Clinical Psychopharmacology 17 (6):485–88. doi:10.1097/00004714-199712000-00008.
   PubMed Web of Science ®Google Scholar
• Hautzinger, M., and M. Bailer. 1993. Allgemeine Depressions-Skala. Weinheim, Germany: Beltz.
   Google Scholar
• Heal, D. J., J. Gosden, and S. L. Smith. 2014. Dopamine reuptake transporter (DAT) “inverse agonism”: A novel hypothesis to explain the enigmatic pharmacology of cocaine. Neuropharmacology 87:19–40. doi:10.1016/j.neuropharm.2014.06.012.
   PubMed Web of Science ®Google Scholar
• Khantzian, E. J. 1983. An extreme case of cocaine dependence and marked improvement with methylphenidate treatment. The American Journal of Psychiatry 140 (6):784–85. doi:10.1176/ajp.140.6.784.
   PubMed Web of Science ®Google Scholar
• Khantzian, E. J., F. Gawin, H. D. Kleber, and C. E. Riordan. 1984. Methylphenidate (Ritalin) treatment of cocaine dependence–a preliminary report. Journal of Substance Abuse Treatment 1 (2):107–12. doi:10.1016/0740-5472(84)90033-3.
   PubMedGoogle Scholar
• Kollins, S. H. 2008. ADHD, substance use disorders, and psychostimulant treatment: Current literature and treatment guidelines. Journal of Attention Disorders 12 (2):115–25. doi:10.1177/1087054707311654.
   PubMed Web of Science ®Google Scholar
• Kollins, S. H., E. K. MacDonald, and C. R. Rush. 2001. Assessing the abuse potential of methylphenidate in nonhuman and human subjects: A review. Pharmacology Biochemistry and Behavior 68 (3):611–27. doi:10.1016/S0091-3057(01)00464-6.
   PubMed Web of Science ®Google Scholar
• Levin, F. R., S. M. Evans, D. J. Brooks, and F. Garawi. 2007. Treatment of cocaine dependent treatment seekers with adult ADHD: Double-blind comparison of methylphenidate and placebo. Drug and Alcohol Dependence 87 (1):20–29. doi:10.1016/j.drugalcdep.2006.07.004.
   PubMed Web of Science ®Google Scholar
• Parran, T., Jr, and D. R. Jasinski. 1991. Intravenous methylphenidate abuse: Prototype for prescription drug abuse. Archives of Internal Medicine 151 (4):781–83. doi:10.1001/archinte.1991.00400040119027.
   PubMedGoogle Scholar
• Peles, E., S. Schreiber, S. Linzy, Y. Domani, and M. Adelson. 2015. Differences in methylphenidate abuse rates among methadone maintenance treatment patients in two clinics. Journal of Substance Abuse Treatment. 54:44–9.
   PubMed Web of Science ®Google Scholar
• Retz-Junginger, P., W. Retz, D. Blocher, H. G. Weijers, G. E. Trott, P. H. Wender, and M. Rossler. 2002. Wender Utah rating scale: The short-version for the assessment of the attention-deficit hyperactivity disorder in adults. Nervenarzt 73 (9):830–38. doi:10.1007/s00115-001-1215-x.
   PubMed Web of Science ®Google Scholar
• Rush, C. R., and R. W. Baker. 2001. Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers. Experimental and Clinical Psychopharmacology 9 (1):59–73. doi:10.1037/1064-1297.9.1.59.
   PubMed Web of Science ®Google Scholar
• Schubiner, H., K. K. Saules, C. L. Arfken, C. E. Johanson, C. R. Schuster, N. Lockhart, A. Edwards, J. Donlin, and E. Pihlgren. 2002. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Experimental and Clinical Psychopharmacology 10 (3):286–94. doi:10.1037/1064-1297.10.3.286.
   PubMed Web of Science ®Google Scholar
• Somoza, E. C., T. M. Winhusen, T. P. Bridge, J. P. Rotrosen, D. G. Vanderburg, J. M. Harrer, J. P. Mezinskis, M. A. Montgomery, D. A. Ciraulo, L. R. Wulsin, and J. A. Barrett. 2004. An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder. Journal of Addictive Diseases 23 (1):77–92. doi:10.1300/J069v23n01_07.
   PubMed Web of Science ®Google Scholar
• Stoops, W. W., P. E. Glaser, and C. R. Rush. 2003. Reinforcing, subject-rated, and physiological effects of intranasal methylphenidate in humans: A dose-response analysis. Drug and Alcohol Dependence 71 (2):179–86. doi:10.1016/S0376-8716(03)00131-5.
   PubMed Web of Science ®Google Scholar
• Strasser, J., G. A. Wiesbeck, N. Meier, R. Stohler, and K. M. Dursteler-Macfarland. 2010. Effects of a single 50% extra dose of methadone on heroin craving and mood in lower- versus higher-dose methadone patients. Journal of Clinical Psychopharmacology 30 (4):450–54. doi:10.1097/JCP.0b013e3181e6df49.
   PubMed Web of Science ®Google Scholar
• van de Glind, G., M. Konstenius, M. W. Koeter, K. Van Emmerik-Van Oortmerssen, P. J. Carpentier, S. Kaye, L. Degenhardt, A. Skutle, J. Franck, E. T. Bu, F. Moggi, G. Dom, S. Verspreet, Z. Demetrovics, M. Kapitany-Foveny, M. Fatseas, M. Auriacombe, A. Schillinger, M. Moller, B. Johnson, S. V. Faraone, J. A. Ramos-Quiroga, M. Casas, S. Allsop, S. Carruthers, R. A. Schoevers, S. Wallhed, C. Barta, P. Alleman, F. R. Levin, and W. van den Brink. 2014. Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: Results from an international multi-center study exploring DSM-IV and DSM-5 criteria. Drug and Alcohol Dependence 134:158–66.
   PubMed Web of Science ®Google Scholar
• van den Brink, W., V. M. Hendriks, P. Blanken, M. W. Koeter, B. J. van Zwieten, and J. M. van Ree. 2003. Medical prescription of heroin to treatment resistant heroin addicts: Two randomised controlled trials. BMJ 327 (7410):310. doi:10.1136/bmj.327.7410.310.
   PubMed Web of Science ®Google Scholar
• Volkow, N. D., Y. S. Ding, J. S. Fowler, G. J. Wang, J. Logan, J. S. Gatley, S. Dewey, C. Ashby, J. Liebermann, R. Hitzemann, et al. 1995. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Archives of General Psychiatry 52 (6):456–63. doi:10.1001/archpsyc.1995.03950180042006.
   PubMed Web of Science ®Google Scholar
• Volkow, N. D., D. Tomasi, G. J. Wang, J. Logan, D. L. Alexoff, M. Jayne, J. S. Fowler, C. Wong, P. Yin, and C. Du. 2014. Stimulant-induced dopamine increases are markedly blunted in active cocaine abusers. Molecular Psychiatry 19 (9):1037–43. doi:10.1038/mp.2014.58.
   PubMed Web of Science ®Google Scholar
• Volkow, N. D., G. J. Wang, J. S. Fowler, M. Fischman, R. Foltin, N. N. Abumrad, S. J. Gatley, J. Logan, C. Wong, A. Gifford, Y. S. Ding, R. Hitzemann, and N. Pappas. 1999. Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain. Life Sciences 65 (1):Pl7–12. doi:10.1016/S0024-3205(99)00225-8.
   PubMed Web of Science ®Google Scholar
• Von Zerssen, D. 1990. Adjective mood scale. In Rating scales for psychiatry – European edition, eds. R. Bischoff, D. Bobon, R. Görtelmeyer, R. Horn, A. A. Müller, K.-D. Stoll, and B. Woggon. Hermsbach, Germany: Beltz.
   Google Scholar
• Wang, G. J., N. D. Volkow, R. J. Hitzemann, C. Wong, B. Angrist, G. Burr, K. Pascani, N. Pappas, A. Lu, T. Cooper, and J. A. Lieberman. 1997. Behavioral and cardiovascular effects of intravenous methylphenidate in normal subjects and cocaine abusers. European Addiction Research 3 (1):49–54. doi:10.1159/000259147.
   Web of Science ®Google Scholar
• Werner, W. 2007. Substitutionstherapie. In Opiatabhängigkeit: Interdisziplinäre aspekte für die praxis, eds. E. Beubler, H. Haltmayer, and A. Springer. Vienna: Springer.
   Google Scholar
• Wilens, T. E. 2003. Drug therapy for adults with attention-deficit hyperactivity disorder. Drugs 63 (22):2395–411. doi:10.2165/00003495-200363220-00002.
   PubMed Web of Science ®Google Scholar
• Wilens, T. E., L. A. Adler, J. Adams, S. Sgambati, J. Rotrosen, R. Sawtelle, L. Utzinger, and S. Fusillo. 2008. Misuse and diversion of stimulants prescribed for ADHD: A systematic review of the literature. Journal of the American Academy of Child and Adolescent Psychiatry 47 (1):21–31.
   PubMed Web of Science ®Google Scholar
• Wilens, T. E., J. Biederman, T. J. Spencer, and R. J. Frances. 1994. Comorbidity of attention-deficit hyperactivity and psychoactive substance use disorders. Hosp Community Psychiatry 45 (5):421–3, 435.
   PubMedGoogle Scholar
• Willey, R. F. 1971. Abuse of methylphenidate (Ritalin). The New England Journal of Medicine 285 (8):464.
   PubMed Web of Science ®Google Scholar
• Winhusen, T., E. Somoza, B. M. Singal, J. Harrer, S. Apparaju, J. Mezinskis, P. Desai, A. Elkashef, C. N. Chiang, and P. Horn. 2006. Methylphenidate and cocaine: A placebo-controlled drug interaction study. Pharmacology, Biochemistry, and Behavior 85 (1):29–38.
   PubMed Web of Science ®Google Scholar